Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Immucell (ICCC) FCF Margin (2016 - 2025)

Immucell's FCF Margin history spans 16 years, with the latest figure at 20.4% for Q4 2025.

  • For Q4 2025, FCF Margin rose 1702.0% year-over-year to 20.4%; the TTM value through Dec 2025 reached 8.94%, up 763.0%, while the annual FY2025 figure was 8.94%, 760.0% up from the prior year.
  • FCF Margin reached 20.4% in Q4 2025 per ICCC's latest filing, up from 32.26% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 22.44% in Q2 2025 to a low of 99.93% in Q1 2023.
  • Average FCF Margin over 5 years is 13.82%, with a median of 3.27% recorded in 2021.
  • Peak YoY movement for FCF Margin: tumbled -9711bps in 2023, then soared 10473bps in 2024.
  • A 5-year view of FCF Margin shows it stood at 2.14% in 2021, then tumbled by -3225bps to 71.29% in 2022, then soared by 120bps to 14.23% in 2023, then crashed by -76bps to 3.38% in 2024, then skyrocketed by 504bps to 20.4% in 2025.
  • Per Business Quant, the three most recent readings for ICCC's FCF Margin are 20.4% (Q4 2025), 32.26% (Q3 2025), and 22.44% (Q2 2025).